secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuronetics, Inc. (STIM)
CIK:        0001227636
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001193125-25-263541
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Neuronetics Q3 revenue $37.3M (+11% adj pro forma); FY guidance cut; CEO Sullivan to retire June 2026
--------------------------------------------------------------------------------

- Revenue $37.3M (+101% YoY, +11% adjusted pro forma); Greenbrook clinic revenue $21.8M (+25% adj pro forma).
- Net loss $(9.4)M ($0.13/shr) vs $(13.3)M ($0.44/shr) last year; gross margin 45.9% (down from 75.6% on business mix).
- Lowers FY2025 revenue guidance to $147-150M (from $149-155M); gross margin 47-49% (from 48-50%).
- CEO Keith Sullivan to retire June 30, 2026; board commenced search; no dispute with management.
- Ended Q3 with $34.5M cash; used $0.8M in ops; secured additional $10M Perceptive debt; raised $7.8M net via ATM.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1227636/000119312525263541/0001193125-25-263541-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1227636/000119312525263541/d98237d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-263541

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer